Skip to collection list Skip to video grid

Vaccine/Immunization

Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment

Little or no difference in safety outcomes was found following LAIV vs IIV or no vaccine, or pre/post-LAIV in individuals with asthma and/or recurrent wheeze.

Click here to read the article
Read More
Read Less

categories

View more in
Vaccine/Immunization

Currently loaded videos are 1 through 15 of 52 total videos.

First page loaded, no previous page available
Load Next Page
3:47
Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment
Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment
4:09
COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects
COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects
4:15
COVID-19 and Completion of Select Routine Childhood Vaccinations
COVID-19 and Completion of Select Routine Childhood Vaccinations
4:13
Cost Analysis of a Scalable Clinician Communication Intervention to Increase HPV Vaccine Initiation
Cost Analysis of a Scalable Clinician Communication Intervention to Increase HPV Vaccine Initiation
4:07
A Bundled, Practice-Based Intervention to Increase HPV Vaccination
A Bundled, Practice-Based Intervention to Increase HPV Vaccination
4:09
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
4:06
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
4:12
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019
3:45
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
3:43
Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine
Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine
4:12
Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State
Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State
4:10
Policy Approaches for Increasing Adolescent HPV Vaccination Coverage: A Systematic Review
Policy Approaches for Increasing Adolescent HPV Vaccination Coverage: A Systematic Review
4:21
Prior Infection and Effectiveness of COVID-19 Vaccination in Middle and High-School Students
Prior Infection and Effectiveness of COVID-19 Vaccination in Middle and High-School Students
4:09
Vaccine Mandates and Influenza Vaccination During the Pandemic
Vaccine Mandates and Influenza Vaccination During the Pandemic
4:11
Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis
Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis

Currently loaded videos are 1 through 15 of 52 total videos.

First page loaded, no previous page available
Load Next Page